SHOVLIN ROBERT J. 4
4 · NEOGENOMICS INC · Filed Mar 5, 2020
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2020-03-04$8.03/sh+96,167$772,221→ 249,733 total - Sale
Common Stock
2020-03-04$30.86/sh−98,093$3,027,150→ 151,640 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-03-04−96,167→ 96,167 totalExercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (96,167 underlying)
Holdings
- 56,271
Stock Option (Right to Buy)
Exercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (56,271 underlying) - 66,667
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (66,667 underlying) - 66,897
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (66,897 underlying)
Footnotes (4)
- [F1]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.